Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation (Review)

Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation (Review)

Background Platelet transfusions are used in modern clinical practice to prevent and treat bleeding in people who are thrombocytopenic due to bone marrow failure. Although considerable advances have been made in platelet transfusion therapy in the last 40 years, some areas continue to provoke debat...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Estcourt, L, Stanworth, SJ, Doree, C, Hopewell, S, Trivella, M, Murphy, MF
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	Wiley 2015

Eitemau Tebyg

Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation
gan: Estcourt, L, et al.
Cyhoeddwyd: (2015)

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation
gan: Crighton, GL, et al.
Cyhoeddwyd: (2015)

Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (protocol)
gan: Estcourt, L, et al.
Cyhoeddwyd: (2014)

Different doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation
gan: Estcourt, L, et al.
Cyhoeddwyd: (2014)

Different platelet count thresholds to guide use of prophylactic platelet transfusions for patients with hematological disorders after myelosuppressive chemotherapy or stem cell transplantation
gan: Estcourt, L, et al.
Cyhoeddwyd: (2016)

Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.
gan: Estcourt, L, et al.
Cyhoeddwyd: (2012)

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation (Russian Translation of Cochrane Plain Language Summary)
gan: Crighton, GL, et al.
Cyhoeddwyd: (2021)

Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation
gan: Desborough, M, et al.
Cyhoeddwyd: (2016)

Prophylactic platelet transfusions prior to surgery for people with a low platelet count
gan: Estcourt, L, et al.
Cyhoeddwyd: (2017)

Prophylactic platelet transfusions prior to surgery for people with a low platelet count
gan: Estcourt, L, et al.
Cyhoeddwyd: (2018)

Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (Protocol).
gan: Estcourt, L, et al.
Cyhoeddwyd: (2014)

Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (protocol)
gan: Estcourt, L, et al.
Cyhoeddwyd: (2014)

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (protocol)
gan: Estcourt, L, et al.
Cyhoeddwyd: (2014)

Prophylactic platelet transfusions
gan: Estcourt, L, et al.
Cyhoeddwyd: (2010)

Comparison of different platelet transfusion thresholds prior to insertion of central lines in patients with thrombocytopenia (Protocol)
gan: Estcourt, L, et al.
Cyhoeddwyd: (2015)

Comparison of different platelet transfusion thresholds prior to insertion of central lines in patients with thrombocytopenia
gan: Estcourt, L, et al.
Cyhoeddwyd: (2015)

Pathogen-reduced platelets for the prevention of bleeding.
gan: Butler, C, et al.
Cyhoeddwyd: (2013)

Pathogen-reduced platelets for the prevention of bleeding (Review)
gan: Estcourt, L, et al.
Cyhoeddwyd: (2017)

Pathogen-reduced platelets for the prevention of bleeding (Review)
gan: Butler, C, et al.
Cyhoeddwyd: (2013)

Alternative agents to prophylactic platelet transfusion for preventing bleeding in people with thrombocytopenia due to chronic bone marrow failure: a meta-analysis and systematic review
gan: Desborough, M, et al.
Cyhoeddwyd: (2016)

Platelet transfusions for patients with haematological malignancies: who needs them?
gan: Estcourt, L, et al.
Cyhoeddwyd: (2011)

Use of platelet transfusions prior to lumbar punctures or epidural anaesthesia for the prevention of complications in people with thrombocytopenia (Protocol)
gan: Estcourt, L, et al.
Cyhoeddwyd: (2015)

Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with thrombocytopenia due to chronic bone marrow failure: a network meta-analysis and systematic review
gan: Desborough, M, et al.
Cyhoeddwyd: (2016)

Alternative agents to prophylactic platelet transfusion for preventing bleeding in people with thrombocytopenia due to chronic bone marrow failure: a meta-analysis and systematic review (Russian translation of Cochrane plain language summary)
gan: Desborough, MJR, et al.
Cyhoeddwyd: (2021)

Pathogen-reduced platelets for the prevention of bleeding (protocol)
gan: Butler, C, et al.
Cyhoeddwyd: (2011)

Prophylactic platelet transfusions in patients with haematological malignancies – lessons from the TOPPS trial
gan: Estcourt, L
Cyhoeddwyd: (2016)

Prophylactic plasma transfusion for patients without inherited bleeding disorders or anticoagulant use undergoing non‐cardiac surgery or invasive procedures
gan: Huber, J, et al.
Cyhoeddwyd: (2018)

Alternatives to prophylactic platelet transfusions
gan: Estcourt, L
Cyhoeddwyd: (2016)

Prophylactic plasma transfusion for patients undergoing non-cardiac surgery
gan: Huber, J, et al.
Cyhoeddwyd: (2017)

A UK national survey of prophylactic platelet transfusion thresholds in non-bleeding, critically ill adults
gan: Shah, A, et al.
Cyhoeddwyd: (2020)

Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: a subgroup analysis of a randomized trial.
gan: Stanworth, S, et al.
Cyhoeddwyd: (2014)

Prophylactic plasma transfusion for patients without inherited bleeding disorders or anticoagulant use undergoing non-cardiac surgery or invasive procedures
gan: Huber, J, et al.
Cyhoeddwyd: (2019)

Use of platelet transfusions prior to lumbar punctures or epidural anaesthesia for the prevention of complications in people with thrombocytopenia
gan: Estcourt, L, et al.
Cyhoeddwyd: (2016)

Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: A subgroup analysis of a randomized trial (CME)
gan: Stanworth, S, et al.
Cyhoeddwyd: (2014)

Feasibility and usefulness of self-assessment of bleeding in patients with haematological malignancies, and the association between platelet count and bleeding.
gan: Stanworth, S, et al.
Cyhoeddwyd: (2006)

Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
gan: Estcourt, L, et al.
Cyhoeddwyd: (2016)

Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological malignancies (Review).
gan: Wardrop, D, et al.
Cyhoeddwyd: (2013)

Anti-fibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders (Protocol)
gan: Wardrop, D, et al.
Cyhoeddwyd: (2016)

Comparison of a therapeutic-only versus prophylactic platelet transfusion policy for people with congenital or acquired bone marrow failure disorders
gan: Ashraf, A, et al.
Cyhoeddwyd: (2016)

The challenges of measuring bleeding outcomes in clinical trials of platelet transfusions.
gan: Estcourt, L, et al.
Cyhoeddwyd: (2013)